Unknown

Dataset Information

0

Single-cell microarray enables high-throughput evaluation of DNA double-strand breaks and DNA repair inhibitors.


ABSTRACT: A key modality of non-surgical cancer management is DNA damaging therapy that causes DNA double-strand breaks that are preferentially toxic to rapidly dividing cancer cells. Double-strand break repair capacity is recognized as an important mechanism in drug resistance and is therefore a potential target for adjuvant chemotherapy. Additionally, spontaneous and environmentally induced DSBs are known to promote cancer, making DSB evaluation important as a tool in epidemiology, clinical evaluation and in the development of novel pharmaceuticals. Currently available assays to detect double-strand breaks are limited in throughput and specificity and offer minimal information concerning the kinetics of repair. Here, we present the CometChip, a 96-well platform that enables assessment of double-strand break levels and repair capacity of multiple cell types and conditions in parallel and integrates with standard high-throughput screening and analysis technologies. We demonstrate the ability to detect multiple genetic deficiencies in double-strand break repair and evaluate a set of clinically relevant chemical inhibitors of one of the major double-strand break repair pathways, non-homologous end-joining. While other high-throughput repair assays measure residual damage or indirect markers of damage, the CometChip detects physical double-strand breaks, providing direct measurement of damage induction and repair capacity, which may be useful in developing and implementing treatment strategies with reduced side effects.

SUBMITTER: Weingeist DM 

PROVIDER: S-EPMC3637349 | biostudies-other | 2013 Mar

REPOSITORIES: biostudies-other

altmetric image

Publications

Single-cell microarray enables high-throughput evaluation of DNA double-strand breaks and DNA repair inhibitors.

Weingeist David M DM   Ge Jing J   Wood David K DK   Mutamba James T JT   Huang Qiuying Q   Rowland Elizabeth A EA   Yaffe Michael B MB   Floyd Scott S   Engelward Bevin P BP  

Cell cycle (Georgetown, Tex.) 20130219 6


A key modality of non-surgical cancer management is DNA damaging therapy that causes DNA double-strand breaks that are preferentially toxic to rapidly dividing cancer cells. Double-strand break repair capacity is recognized as an important mechanism in drug resistance and is therefore a potential target for adjuvant chemotherapy. Additionally, spontaneous and environmentally induced DSBs are known to promote cancer, making DSB evaluation important as a tool in epidemiology, clinical evaluation a  ...[more]

Similar Datasets

| S-EPMC7544215 | biostudies-literature
| S-EPMC6137971 | biostudies-literature
| S-EPMC6036208 | biostudies-literature
| S-EPMC4030556 | biostudies-literature
| S-EPMC6036207 | biostudies-literature
| S-EPMC3980576 | biostudies-literature
| S-EPMC4331074 | biostudies-literature
| S-EPMC5576896 | biostudies-literature
| S-EPMC7464352 | biostudies-literature
| S-EPMC4398330 | biostudies-literature